	The future promise of antibody-drug conjugates in extensive-stage small cell lung cancer. Cancer Sethakorn N, Chiang AC. PMID: 42226003 [PubMed - in process]
	SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial. Nat Med Byers LA, Cho BC, Cooper AJ, Chiang AC, Han JY, Furqan M, Dowlati A, Morgensztern D, Papadopoulos KP, Choudhury NJ, Vieito M, Bar J, Kim JH, Akerley W, Kim TM, Kim YC, Paz-Ares L, Ahn MJ, Yokouchi H, Meiman D, Munasinghe W, Ogunyankin O, Jahchan N, Wang S, Ferlini C, Robinson RR, Kohlhapp FJ, Palenski T, Rivell G, Hingorani P, Chandana S. PMID: 42225988 [PubMed - as supplied by publisher]
	Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial. Signal Transduct Target Ther Zhao Q, Li Y, Zhang H, Han D, Kan Y, Sun H, Liu C, Wang L, Han X, Hua Y, Wang X, Fu C, Wang Z, Du X, Liu J, Li B, Huang W. PMID: 42225651 [PubMed - in process]
	Lung cancer risk prediction models and asbestos exposure: a validation study on the Western Australia Asbestos Review Program. Occup Environ Med Kumarasamy C, Betts K, Norman R, Bennett K, Franklin P, Tammemägi M, Brims F. PMID: 42225416 [PubMed - as supplied by publisher]
	Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: insights into mechanisms and therapeutic opportunities. Crit Rev Oncol Hematol Guan R, Zhang C, Zhang J, Du S, Wang H, Zhang Y, Abdi AAM, Wang H. PMID: 42225194 [PubMed - as supplied by publisher]
	Advances in the management of small cell lung cancer: thoracic and cranial radiation therapy and sequencing with systemic therapy. Cancer Treat Res Commun Liefman D, Lehman M. PMID: 42225009 [PubMed - as supplied by publisher]
	The patient experience of pathways to lung cancer diagnosis in primary care: A mixed methods investigation of factors influencing timeliness of diagnosis. Patient Educ Couns Mander K, Yap A, Galpin K, Decaria A, Laidsaar-Powell R, Brown B. PMID: 42224915 [PubMed - as supplied by publisher]
	SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma. Crit Rev Immunol Feng X, Gao L, Xue Y, Zhang Y, Cao H, Wange T. PMID: 42224680 [PubMed - in process]
	Standard Versus Reduced Sotorasib Dosing in KRAS G12C-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis-Have We Answered the Dosing Question? JCO Oncol Pract Aung WY, Neumann M, Wang KY, Chukkalore D, Morales J, Seetharamu N. PMID: 42224643 [PubMed - as supplied by publisher]
	Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial. JAMA Chaft JE, Sun Z, Rudin CM, Khullar OV, Simone CB 2nd, Oettel K, Kozono D, Sunkara R, Faller B, Isbell JM, Hugec V, Shipstone A, McGary EC, Clarke JM, Talsania A, Ding L, Govindan R, Sands JM, Heymach JV, Raez LE, Malik SM, Stinchcombe TE, Mandrekar SJ, Bradley J, Gerber DE, Vokes E, Gandara D, Staley C, Ramalingam SS. PMID: 42224490 [PubMed - as supplied by publisher]
	Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection. JAMA Netw Open Madeka I, Noueihed K, Woodroof J, Mack S, Rshaidat H, Whitehorn GL, Alaparthi S, Koeneman SH, Grenda TR, Evans NR 3rd, Okusanya OT. PMID: 42223938 [PubMed - indexed for MEDLINE]
	Nonlinear relationship between rheumatoid arthritis disease duration and lung cancer risk in a Chinese cohort: a threshold effect study. Intern Emerg Med Li J, Li S, Wang X, Liu W. PMID: 42223853 [PubMed - as supplied by publisher]
	Renal and Extramedullary Involvement Revealing Atypical Multiple Myeloma: A Case Report and a Literature Review. Tunis Med El Ati Z, Hadhri A, Dahmane R, Ayed A, Hadj Brahim M, Boukadida R, Zouaghi K, Jaballah L, Raies L. PMID: 42223467 [PubMed - indexed for MEDLINE]
	Prognostic factors for stage III/IV bronchopulmonary cancers in the North-West region of Tunisia. Tunis Med Mahjoub N, Khiari H, Slama A, Ben Hssine S, Boukhriss S, Fehri R, Rjiba R, Jaffel H. PMID: 42223462 [PubMed - indexed for MEDLINE]
	Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med Wu YL, Hochmair M, Yang Y, Yang XN, Tsuboi M, Paz-Ares L, Yang JC, Wu L, Kim HR, Rieke DT, Johnson M, Besse B, Sharma N, Maeda P, Peterson P, Lin BK, Frimodt-Moller B, Goldman J, Drilon A, LIBRETTO-432 Trial Investigators. PMID: 42223087 [PubMed - as supplied by publisher]
	An autoantibody signature targeting cuproptosis-related proteins for non-small cell lung cancer detection and prognosis. PeerJ Liu A, Zhang L, Yu P, Nie T, Cao X, Li J, Sun W, Liang Y, Ouyang S, Dai L, Liu J. PMID: 42222481 [PubMed - indexed for MEDLINE]
	18F-FDG PET/CT for predicting major pathological response to neoadjuvant therapy in non-small cell lung cancer: a meta-analysis. Front Oncol Wu Y, Hu B, Liu D, Meng H. PMID: 42222426 [PubMed]
	Aseptic inflammatory abscesses induced by crizotinib in a case report of ALK rearrangement lung adenocarcinoma. Front Oncol Huang H, Wang K, Zhai X, Cheng P, Li H, Qiu W, Peng T, Cao L, Luo Q, Wang Z. PMID: 42222397 [PubMed]
	The evolving role of the immune microenvironment of tumor draining lymph nodes in the development of biomarkers of non-small cell lung cancer. Front Oncol Xi ZH, Zollinger B, Koga Y, Weis J, Campbell JD, Mazzilli SA, Suzuki K. PMID: 42222378 [PubMed]
	Interpretable multi-center machine learning model driven by facial image features for non-invasive early risk assessment of lung cancer. Front Physiol Shi Y, Chun Y, Zhang S, Xu X, Chen W, Jiao L, Wang L, Tu L, Xu J. PMID: 42222284 [PubMed]

Articles 1 - 20 / 160113

Page 1 of 8006



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy